Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
100%
Glycogen Synthase Kinase 3
100%
Fluoxetine
100%
Lipopolysaccharide
45%
Glycogen Synthase Kinase 3beta
45%
Inducible Nitric Oxide Synthase
27%
Prostaglandin E2
27%
Nitric Oxide
27%
Reactive Oxygen Metabolite
18%
Cyclooxygenase 2
18%
Inflammation
18%
Mortality Rate
9%
Mouse
9%
Mitogen Activated Protein Kinase
9%
Phosphatidylinositol 3 Kinase
9%
2 Morpholino 8 Phenylchromone
9%
Protein Kinase B Inhibitor
9%
Peroxisome Proliferator Activated Receptor
9%
Lipopolysaccharide-Induced Inflammation
9%
Peroxisome Proliferator Activated Receptor Antagonist
9%
Selective Serotonin Reuptake Inhibitor
9%
Wortmannin
9%
Neuroscience
Anti-Inflammatory
100%
Glycogen Synthase Kinase 3
100%
Fluoxetine
100%
Lipopolysaccharide
54%
Glycogen Synthase Kinase 3beta
45%
Nitric Oxide
27%
Inducible Nitric Oxide Synthase
27%
Prostaglandin E2
27%
Reactive Oxygen Species
18%
Cyclooxygenase 2
18%
Peroxisome Proliferator-Activated Receptor
18%
Mitogen-Activated Protein Kinase
9%
Receptor Antagonist
9%
Macrophage
9%
Wortmannin
9%
Phosphoinositide 3-Kinase
9%
LY294002
9%
Treatment of Depression
9%
Selective Serotonin Reuptake Inhibitor
9%